Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant protein vaccines have been widely used in the real world and shown good protective effects. A vaccine prepared from the ancestral SARS-CoV-2 receptor-binding domain (RBD) homodimer was previously made a candidate in view of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yan, Shi, Jian, He, Xiaoxue, Lu, Jia, Gao, Xiao, Zhu, Xuerui, Chen, Xinlan, Zhang, Man, Fang, Lijuan, Zhang, Jing, Yuan, Zhiming, Xiao, Gengfu, Zhou, Pengfei, Pan, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688353/
https://www.ncbi.nlm.nih.gov/pubmed/37843372
http://dx.doi.org/10.1128/jvi.01279-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688353/
https://www.ncbi.nlm.nih.gov/pubmed/37843372
http://dx.doi.org/10.1128/jvi.01279-23

Ejemplares similares